Business context and reporting period
AdvanSix Inc. filed this Form 10-K for the fiscal year ended December 31, 2019. The company is an integrated U.S. manufacturer of Nylon 6 resin, caprolactam, ammonium sulfate fertilizer and chemical intermediates, including acetone. It operates three manufacturing sites and reports one operating and reportable segment.
2019 sales mix: chemical intermediates 28%, Nylon 27%, ammonium sulfate 23% and caprolactam 22%. Shaw Industries was the largest customer, representing 22% of sales; the ten largest customers together represented 47%.
Financial performance and liquidity
| Metric | 2019 | 2018 |
|---|---|---|
| Sales | $1,297.4 million | $1,515.0 million |
| Gross profit / gross margin | $135.5 million / 10.4% | $174.5 million / 11.5% |
| Net income | $41.3 million | $66.2 million |
| Diluted EPS | $1.43 | $2.14 |
| EBITDA / EBITDA margin (non-GAAP) | $115.6 million / 8.9% | $146.5 million / 9.7% |
| Operating cash flow | $120.4 million | $173.4 million |
| Capital expenditures | $150.3 million | $109.2 million |
Sales fell 14.4% year over year: prices declined 10.8% and volume fell 3.6%. Net income decreased 37.6%. Capital spending exceeded operating cash flow by approximately $29.9 million. Cash at year-end was $7.1 million.
At December 31, 2019, debt under the revolving credit facility was $297.0 million, versus $200.0 million a year earlier; the $425 million facility matures in February 2023. The company was compliant with its credit covenants at year-end. Current assets of $290.5 million were slightly below current liabilities of $291.7 million. Operating lease liabilities totaled $136.4 million following adoption of the new lease accounting standard. Total liabilities were $835.1 million and equity was $400.9 million.
Fourth-quarter 2019 sales were $326.7 million, gross profit was $14.9 million, and the company recorded a net loss of $2.1 million, or diluted loss per share of $0.08. The comparable fourth-quarter 2018 figures were sales of $386.6 million, gross profit of $53.8 million and net income of $20.8 million.
Material changes versus the prior comparable period
- Lower formula-based prices, particularly reflecting benzene and propylene feedstock costs, and weaker market pricing for acetone and nylon drove most of the sales decline. Lower volume reflected the phenol force majeure, challenging acetone conditions and unfavorable product mix; higher caprolactam utilization partly offset the volume pressure.
- Gross margin declined by 1.1 percentage points. Lower volume and unfavorable mix, lower nylon and acetone pricing, PES-related costs and Pottsville restructuring costs outweighed benefits from formula-based pass-through pricing, improved yields and lower plant spending.
- Operating cash flow decreased by $53.0 million, reflecting lower earnings and a less favorable working-capital contribution. Capital expenditures rose by $41.1 million.
- The company closed its Pottsville, Pennsylvania films plant in July 2019 and recorded an $11.0 million restructuring charge. It formed a strategic alliance with Oben for flexible-packaging films, using AdvanSix sales channels and Nylon 6 supply.
- Debt increased by $97.0 million net during 2019, while cash declined by $2.8 million.
Outlook, management commentary, risks and unusual items
- Management expected 2020 capital expenditures of approximately $90–$100 million. No full-year revenue or earnings guidance is stated in the provided filing text.
- The PES refinery shutdown increased raw-material and logistics costs. AdvanSix estimated an unfavorable pretax impact of $10–$15 million in 2020, or $0–$5 million more than the full-year 2019 impact.
- A March 2019 cumene supply disruption caused a phenol force majeure and reduced phenol and caprolactam production. The company reported approximately $6.9 million of first-quarter pretax impact from fixed-cost absorption and logistics, plus lost-sales impacts of $1.4 million in the first quarter and $2.3 million in the second quarter. The force majeure had ended.
- In February 2020, the company amended its credit agreement to provide additional leverage-covenant flexibility. The amendment retained a minimum 3.00-to-1.00 interest-coverage covenant and revised leverage limits; it is a subsequent event, not a year-end 2019 balance-sheet change.
- Principal risks include cyclical and volatile product pricing, raw-material supply and cost exposure, integrated-plant downtime, customer concentration, environmental and safety obligations, and debt covenant and refinancing risks. The company reported no material off-balance-sheet arrangements.
- The Hopewell air-emissions criminal investigation concluded in 2019 with no further action required. Management stated that known environmental remediation costs were not expected to be material in 2020; broader environmental contingencies remain a risk.
- The 2019 results included $11.0 million of Pottsville restructuring charges. A 2018 weather-related interruption generated approximately $12 million of business-interruption insurance benefits recorded across late 2018 and the first half of 2019.
Important facts for investors to verify
- Whether margins and cash generation recover amid lower market prices, soft end-market demand and product-mix pressure.
- Actual 2020 cost and supply effects from the PES shutdown, cumene sourcing changes and logistics realignment relative to the $10–$15 million pretax estimate.
- Available revolver capacity, borrowing costs and covenant headroom under the February 2020 amendment, including the effects of variable rates and LIBOR transition.
- Execution and financial impact of the Pottsville closure and Oben alliance, and progress in developing higher-value differentiated products.
- Exposure to Shaw and other major customers, environmental liabilities, and planned pension contributions of $5–$10 million in 2020.